PEPTIDE-SPECIFIC NANOLIPOSOME TECHNOLOGY​​​​​​​

Nanoliposome manufacturing,
​​​​​​​built specifically for peptides.

A closed, vacuum-sealed production platform engineered to encapsulate peptide-based active ingredients at documented efficiency above 90%  for pharmaceutical, biotechnology, and cosmetic manufacturers across Europe.

      KEY METRICS STRIP

O2

        THE CHALLENGE

Peptides are powerful.
​​​​​​​Manufacturing them well is the hard part​​​​.

Peptide-based actives degrade under oxidative conditions, lose activity outside narrow temperature ranges, and break down before reaching their target.

Nanoliposomal encapsulation is the industry’s answer, but most production systems weren’t designed specifically for peptides, and typically deliver 60–75% encapsulation efficiency with meaningful batch-to-batch variability.

Vacuum-sealed, closed-loop
Eliminates atmospheric oxygen throughout processing — the primary cause of peptide oxidative degradation.

Dual-reservoir architecture
Separates lipid-phase homogenization from final nanometric dispersion, for precise control at each stage.

      THE SOLUTION

      OFFERING & ENGAGEMENT MODELS

Platform License

​​​​​​​Technology licensing for manufacturers who want the platform inside their own facility.

Nanoliposomal Pharmaceutical Peptide APIs

Pharmaceutical peptide APIs developed through our specialised formulation and nanoliposomal production platform.​​​​​​​

Proprietary Intellectual Property
The platform is protected under WIPO PCT application PCT/IB2025/056596. Following full international search and examination, all 21 claims were confirmed as novel, inventive, and industrially applicable.

PATENT & TECHNOLOGY BANNER

Partners & Network
​​​​​​​Trusted by partners across Europe and India

​​​​​​​Discuss your project requirements, request a technical evaluation, or order sample batches starting from 100g.